Literature DB >> 2964562

A new natriuretic peptide in porcine brain.

T Sudoh1, K Kangawa, N Minamino, H Matsuo.   

Abstract

Atrial natriuretic peptide (ANP), a hormone secreted from mammalian atria, regulates the homoeostatic balance of body fluid and blood pressure. ANP-like immunoreactivity is also present in the brain, suggesting that the peptide functions as a neuropeptide. We report here identification in porcine brain of a novel peptide of 26 amino-acid residues, eliciting a pharmacological spectrum very similar to that of ANP, such as natriuretic-diuretic, hypotensive and chick rectum relaxant activities. The complete amino-acid sequence determined for the peptide is remarkably similar to but definitely distinct from the known sequence of ANP, indicating that the genes for the two are distinct. Thus, we have designated the peptide 'brain natriuretic peptide' (BNP). The occurrence of BNP with ANP in mammalian brain suggests the possibility that the physiological functions so far thought to be mediated by ANP may be regulated through a dual mechanism involving both ANP and BNP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2964562     DOI: 10.1038/332078a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  238 in total

1.  Three dimensional atomic model and experimental validation for the ATP-Regulated Module (ARM) of the atrial natriuretic factor receptor guanylate cyclase.

Authors:  T Duda; P Yadav; A Jankowska; V Venkataraman; R K Sharma
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

2.  Inhibition of atrial natriuretic peptide (ANP) C receptor expression by antisense oligodeoxynucleotides in A10 vascular smooth-muscle cells is associated with attenuation of ANP-C-receptor-mediated inhibition of adenylyl cyclase.

Authors:  A Palaparti; Y Li; M B Anand-Srivastava
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

3.  Three dimensional atomic model and experimental validation for the ATP-Regulated Module (ARM) of the atrial natriuretic factor receptor guanylate cyclase.

Authors:  T Duda; P Yadav; A Jankowska; V Venkataraman; R K Sharma
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

Review 4.  Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.

Authors:  S Talwar; P F Downie; L L Ng; I B Squire
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

5.  The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting.

Authors:  Osman Saribulbul; Ilker Alat; Senol Coskun; Anil Z Apaydin; Tahir Yagdi; Mefkure Kiliccioglu; Emin Alp Alayunt
Journal:  Tex Heart Inst J       Date:  2003

6.  B Type natriuretic peptide: a good omen in myocardial ischaemia?

Authors:  S P D'Souza; G F Baxter
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

7.  Effects of atrial natriuretic peptide and vasopressin on chloride transport in long- and short-looped medullary thick ascending limbs.

Authors:  H Nonoguchi; K Tomita; F Marumo
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Conservation of the kinaselike regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases.

Authors:  K J Koller; F J de Sauvage; D G Lowe; D V Goeddel
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

9.  Brain natriuretic peptide and fluid volume homeostasis--studies during cardiopulmonary bypass surgery.

Authors:  A Ationu; M Burch; M Elliott; N Carter
Journal:  Clin Auton Res       Date:  1993-08       Impact factor: 4.435

10.  Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.

Authors:  N Yokota; B G Bruneau; M L Kuroski de Bold; A J de Bold
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.